Nicholas Joseph Swerdlow, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endovascular Procedures | 31 | 2023 | 2179 | 2.840 |
Why?
|
Aortic Aneurysm, Abdominal | 23 | 2023 | 1229 | 2.790 |
Why?
|
Blood Vessel Prosthesis Implantation | 21 | 2023 | 1426 | 2.310 |
Why?
|
Endoleak | 5 | 2022 | 111 | 1.020 |
Why?
|
Blood Vessel Prosthesis | 11 | 2023 | 954 | 1.020 |
Why?
|
Stents | 11 | 2020 | 3177 | 1.010 |
Why?
|
Aortic Aneurysm, Thoracic | 5 | 2023 | 696 | 0.920 |
Why?
|
Vascular Surgical Procedures | 6 | 2020 | 1490 | 0.740 |
Why?
|
Postoperative Complications | 18 | 2023 | 15627 | 0.660 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2019 | 92 | 0.640 |
Why?
|
Carotid Artery Diseases | 3 | 2020 | 872 | 0.610 |
Why?
|
Carotid Stenosis | 6 | 2020 | 860 | 0.610 |
Why?
|
Aortic Aneurysm | 2 | 2020 | 648 | 0.580 |
Why?
|
Vascular Grafting | 1 | 2019 | 162 | 0.570 |
Why?
|
Endarterectomy, Carotid | 5 | 2020 | 555 | 0.560 |
Why?
|
Aortic Rupture | 4 | 2021 | 319 | 0.560 |
Why?
|
Aortography | 1 | 2018 | 420 | 0.550 |
Why?
|
Radiography, Interventional | 2 | 2018 | 1121 | 0.460 |
Why?
|
Prosthesis Design | 6 | 2020 | 2115 | 0.450 |
Why?
|
Femoral Artery | 4 | 2020 | 827 | 0.400 |
Why?
|
Catheterization, Peripheral | 3 | 2020 | 342 | 0.390 |
Why?
|
Time Factors | 28 | 2022 | 39947 | 0.370 |
Why?
|
Treatment Outcome | 35 | 2023 | 64591 | 0.330 |
Why?
|
Risk Assessment | 22 | 2021 | 23953 | 0.320 |
Why?
|
Risk Factors | 33 | 2023 | 74055 | 0.310 |
Why?
|
Stroke | 9 | 2023 | 9745 | 0.310 |
Why?
|
Aorta, Abdominal | 3 | 2020 | 625 | 0.310 |
Why?
|
Imaging, Three-Dimensional | 2 | 2018 | 4063 | 0.300 |
Why?
|
Retrospective Studies | 35 | 2023 | 80430 | 0.280 |
Why?
|
Aged, 80 and over | 27 | 2022 | 58859 | 0.280 |
Why?
|
Databases, Factual | 13 | 2021 | 7948 | 0.270 |
Why?
|
Eligibility Determination | 2 | 2021 | 420 | 0.270 |
Why?
|
Registries | 11 | 2021 | 8216 | 0.240 |
Why?
|
Aortic Diseases | 2 | 2021 | 737 | 0.230 |
Why?
|
Aged | 38 | 2023 | 168840 | 0.230 |
Why?
|
Aorta, Thoracic | 2 | 2021 | 1097 | 0.220 |
Why?
|
Spinal Cord Ischemia | 1 | 2023 | 94 | 0.200 |
Why?
|
Protamines | 1 | 2020 | 112 | 0.170 |
Why?
|
Clinical Enzyme Tests | 1 | 2020 | 115 | 0.170 |
Why?
|
Subclavian Artery | 1 | 2020 | 134 | 0.170 |
Why?
|
Quality Indicators, Health Care | 2 | 2020 | 1792 | 0.170 |
Why?
|
Hospital Mortality | 7 | 2021 | 5283 | 0.160 |
Why?
|
Groin | 1 | 2019 | 106 | 0.160 |
Why?
|
Male | 38 | 2022 | 360035 | 0.150 |
Why?
|
Aspartate Aminotransferases | 1 | 2020 | 417 | 0.150 |
Why?
|
Product Surveillance, Postmarketing | 2 | 2019 | 452 | 0.150 |
Why?
|
Remission, Spontaneous | 1 | 2018 | 384 | 0.150 |
Why?
|
Female | 40 | 2022 | 391875 | 0.150 |
Why?
|
Fluoroscopy | 2 | 2018 | 947 | 0.140 |
Why?
|
Platelet Count | 1 | 2020 | 780 | 0.140 |
Why?
|
Ischemic Attack, Transient | 2 | 2020 | 878 | 0.140 |
Why?
|
Angioplasty | 1 | 2019 | 354 | 0.130 |
Why?
|
Intermittent Claudication | 1 | 2018 | 304 | 0.130 |
Why?
|
Patient Discharge | 2 | 2020 | 3436 | 0.130 |
Why?
|
Propensity Score | 2 | 2020 | 1906 | 0.130 |
Why?
|
Device Removal | 1 | 2020 | 630 | 0.120 |
Why?
|
Humans | 46 | 2023 | 760437 | 0.120 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2018 | 474 | 0.110 |
Why?
|
Gastric Bypass | 3 | 2011 | 817 | 0.110 |
Why?
|
Thromboembolism | 1 | 2020 | 996 | 0.110 |
Why?
|
Emergencies | 1 | 2020 | 1217 | 0.110 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 840 | 0.110 |
Why?
|
United States | 15 | 2023 | 72202 | 0.110 |
Why?
|
Middle Aged | 20 | 2021 | 220382 | 0.100 |
Why?
|
Sigma Factor | 1 | 2013 | 176 | 0.100 |
Why?
|
Borrelia burgdorferi | 1 | 2013 | 183 | 0.090 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1218 | 0.090 |
Why?
|
RNA, Bacterial | 1 | 2013 | 393 | 0.090 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2011 | 91 | 0.090 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1494 | 0.090 |
Why?
|
Oxyntomodulin | 1 | 2010 | 8 | 0.090 |
Why?
|
Lower Extremity | 1 | 2018 | 1199 | 0.090 |
Why?
|
Embolization, Therapeutic | 1 | 2020 | 1418 | 0.090 |
Why?
|
Surgery, Computer-Assisted | 1 | 2018 | 1007 | 0.090 |
Why?
|
Radiation Dosage | 1 | 2018 | 1958 | 0.090 |
Why?
|
Ischemia | 1 | 2018 | 1876 | 0.080 |
Why?
|
Vascular Diseases | 1 | 2018 | 1161 | 0.080 |
Why?
|
Comprehension | 1 | 2015 | 620 | 0.080 |
Why?
|
Liver Cirrhosis | 1 | 2020 | 1934 | 0.080 |
Why?
|
Preoperative Care | 1 | 2018 | 2242 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 3243 | 0.080 |
Why?
|
Blood Platelets | 1 | 2020 | 2478 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2018 | 12127 | 0.080 |
Why?
|
Caloric Restriction | 1 | 2011 | 299 | 0.080 |
Why?
|
Punctures | 2 | 2020 | 366 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1847 | 0.080 |
Why?
|
Odds Ratio | 1 | 2020 | 9639 | 0.070 |
Why?
|
Peripheral Arterial Disease | 1 | 2018 | 1271 | 0.070 |
Why?
|
Patient Selection | 4 | 2019 | 4240 | 0.070 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15257 | 0.070 |
Why?
|
Asymptomatic Diseases | 2 | 2019 | 587 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2018 | 3076 | 0.060 |
Why?
|
Patient Readmission | 1 | 2019 | 3249 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3798 | 0.060 |
Why?
|
Obesity | 3 | 2011 | 12918 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3344 | 0.060 |
Why?
|
Insulin | 1 | 2018 | 6591 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 3439 | 0.060 |
Why?
|
Canada | 2 | 2020 | 2119 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10180 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2462 | 0.050 |
Why?
|
Survival Rate | 3 | 2020 | 12698 | 0.050 |
Why?
|
Length of Stay | 3 | 2020 | 6413 | 0.050 |
Why?
|
Blood Glucose | 2 | 2018 | 6380 | 0.050 |
Why?
|
Heparin Antagonists | 1 | 2020 | 34 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 3996 | 0.040 |
Why?
|
Constriction | 1 | 2019 | 171 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2015 | 4226 | 0.040 |
Why?
|
Reoperation | 2 | 2020 | 4300 | 0.040 |
Why?
|
Weight Loss | 1 | 2011 | 2683 | 0.040 |
Why?
|
Bacterial Proteins | 1 | 2013 | 3842 | 0.040 |
Why?
|
Hospitalization | 1 | 2019 | 10698 | 0.040 |
Why?
|
Singapore | 1 | 2020 | 291 | 0.040 |
Why?
|
Embolic Protection Devices | 1 | 2019 | 42 | 0.040 |
Why?
|
Multilevel Analysis | 1 | 2018 | 150 | 0.040 |
Why?
|
After-Hours Care | 1 | 2018 | 102 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 12785 | 0.040 |
Why?
|
Age Factors | 3 | 2019 | 18379 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10538 | 0.030 |
Why?
|
Logistic Models | 2 | 2020 | 13240 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2281 | 0.030 |
Why?
|
Patient Admission | 1 | 2021 | 1367 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2642 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 2018 | 985 | 0.030 |
Why?
|
5' Untranslated Regions | 1 | 2013 | 256 | 0.020 |
Why?
|
Carnitine | 1 | 2011 | 252 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 2010 | 866 | 0.020 |
Why?
|
Ribosomes | 1 | 2013 | 501 | 0.020 |
Why?
|
Genes, Bacterial | 1 | 2013 | 1079 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7230 | 0.020 |
Why?
|
Inpatients | 1 | 2020 | 2545 | 0.020 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2011 | 269 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 943 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 2750 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8466 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2518 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2010 | 1178 | 0.020 |
Why?
|
Hemorrhage | 1 | 2019 | 3414 | 0.020 |
Why?
|
Animals | 1 | 2019 | 168253 | 0.020 |
Why?
|
Diet, Reducing | 1 | 2010 | 485 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2011 | 787 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 1633 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2013 | 2114 | 0.020 |
Why?
|
Thrombosis | 1 | 2019 | 2940 | 0.020 |
Why?
|
Medicare | 1 | 2023 | 6732 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7996 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9309 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3800 | 0.010 |
Why?
|
Cohort Studies | 2 | 2019 | 41366 | 0.010 |
Why?
|
Mass Screening | 1 | 2018 | 5424 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12449 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21322 | 0.010 |
Why?
|
Regression Analysis | 1 | 2011 | 6340 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11453 | 0.010 |
Why?
|
Adult | 4 | 2015 | 220781 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 26063 | 0.010 |
Why?
|
Mutation | 1 | 2013 | 30025 | 0.000 |
Why?
|
Prospective Studies | 1 | 2011 | 54339 | 0.000 |
Why?
|